Browsing by Author "Haugaa, Kristina H."

Now showing 1 - 3 of 3

Cardiovascular Multimodality Imaging In Women: A Scientific Statement Of The European Association Of Cardiovascular Imaging Of The European Society Of Cardiology
(Başkent Üniversitesi Sağlık Bilimleri Fakültesi, 2024-03-27) Almeida, Ana G.; Grapsa, Julia; Gimelli, Alessia; Bucciarelli-Ducci, Chiara; Gerber, Bernhard; Ajmone-Marsan, Nina; Bernard, Anne; Donal, Erwan; Dweck, Marc R.; Haugaa, Kristina H.; Hristova, Krassimira; Maceira, Alicia; Mandoli, Giulia Elena; Mulvagh, Sharon; Morrone, Doralisa; Plonska-Gosciniak, Edyta; Sade, Leyla Elif; Shivalkar, Bharati; Schulz-Menger, Jeanette; Shaw, Leslee; Sitges, Marta; von Kemp, Berlinde; Pinto, Fausto J.; Edvardsen, Thor; Petersen, Steffen E.; Cosyns, Bernard
Cardiovascular diseases (CVD) represent an important cause of mortality and morbidity in women. It is now recognized that there are sex differences regarding the prevalence and the clinical significance of the traditional cardiovascular (CV) risk factors as well as the pathology underlying a range of CVDs. Unfortunately, women have been under-represented in most CVD imaging studies and trials regarding diagnosis, prognosis, and therapeutics. There is therefore a clear need for further investigation of how CVD affects women along their life span. Multimodality CV imaging plays a key role in the diagnosis of CVD in women as well as in prognosis, decision-making, and monitoring of therapeutics and interventions. However, multimodality imaging in women requires specific consideration given the differences in CVD between the sexes. These differences relate to physiological changes that only women experience (e.g. pregnancy and menopause) as well as variation in the underlying pathophysiology of CVD and also differences in the prevalence of certain conditions such as connective tissue disorders, Takotsubo, and spontaneous coronary artery dissection, which are all more common in women. This scientific statement on CV multimodality in women, an initiative of the European Association of Cardiovascular Imaging of the European Society of Cardiology, reviews the role of multimodality CV imaging in the diagnosis, management, and risk stratification of CVD, as well as highlights important gaps in our knowledge that require further investigation.
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel
(2020) Skulstad, Helge; Cosyns, Bernard; Popescu, Bogdan A.; Galderisi, Maurizio; Di Salvo, Giovanni; Donal, Erwan; Petersen, Steffen; Gimelli, Alessia; Haugaa, Kristina H.; Muraru, Denisa; Almeida, Ana G.; Schulz-Menger, Jeanette; Dweck, Marc R.; Pontone, Gianluca; Sade, Leyla Elif; Gerber, Bernhard; Maurovich-Horvat, Pal; Bharucha, Tara; Cameli, Matteo; Magne, Julien; Westwood, Mark; Maurer, Gerald; Edvardsen, Thor; 32242891
The year 2019 in the European Heart Journal - Cardiovascular Imaging: part II
(2020) Cosyns, Bernard; Haugaa, Kristina H.; Gerber, Bernrhard; Gimelli, Alessia; Sade, Leyla Elif; Maurer, Gerald; Popescu, Bogdan A.; Edvardsen, Thor; 33188688
The European Heart Journal - Cardiovascular Imaging was Launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journal. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal from 2019 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. While Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging.